DOI:
10.1055/s-00032260
Digestive Disease Interventions
LinksClose Window
References
Shaverdian N, Lisberg AE, Bornazyan K. et al.
Previous radiotherapy and the clinical activity and toxicity of pembrolizumab in the treatment of non-small-cell lung cancer: a secondary analysis of the KEYNOTE-001 phase 1 trial.
Lancet Oncol 2017;
18 (07) 895-903
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.